Search results
Results From The WOW.Com Content Network
The artificial sweetener aspartame has been the subject of several controversies since its initial approval by the U.S. Food and Drug Administration (FDA) in 1974. The FDA approval of aspartame was highly contested, beginning with suspicions of its involvement in brain cancer, [1] alleging that the quality of the initial research supporting its safety was inadequate and flawed, and that ...
Health groups ‘advising a bit of moderation’ on aspartame consumption
Aspartame is a methyl ester of the dipeptide of the natural amino acids L-aspartic acid and L-phenylalanine. [4] Under strongly acidic or alkaline conditions, aspartame may generate methanol by hydrolysis. Under more severe conditions, the peptide bonds are also hydrolyzed, resulting in free amino acids. [53]
The artificial sweetener aspartame is under scrutiny for potential health risks, including cancer. What is aspartame and its health risks, if any? Aspartame, cancer and other health risks: What ...
For premium support please call: 800-290-4726 more ways to reach us
Blaylock completed his general surgical internship and neurosurgical residency at the Medical University of South Carolina in Charleston, SC. [4] He was licensed to practice Neurological Surgery in North Carolina between May 6, 1977, and December 15, 2006. [5]
FDA scientists do not have safety concerns when aspartame is used under the approved conditions,” the FDA said in a statement. Aspartame is sold under the names Equal, Nutrasweet and Sugar Twin.
Reported neurological symptoms include difficulty sleeping, decrease in intellectual capacity, dizziness, altered visual perceptive abilities, affected psychomotor skills, forgetfulness, and disorientation. [6] [8] The mechanism behind these symptoms beyond solvent molecules crossing the blood–brain barrier is currently unknown.